LRP10 in α-synucleinopathies

LRP10 in α-synucleinopathies

Bibliographic Details
Main Authors:	Guerreiro, R, Orme, T, Neto, JL, Bras, J, Parkkinen, L, Ansorge, O
Other Authors:	International DLB Genetics Consortium
Format:	Journal article
Language:	English
Published:	Elsevier 2018

Similar Items

Selective vulnerability in α-synucleinopathies.
by: Alegre-Abarrategui, J, et al.
Published: (2019)

Comparative proteomic analysis highlights metabolic dysfunction in α-synucleinopathy
by: Sarkar, Souvarish, et al.
Published: (2021)

Comparative proteomic analysis highlights metabolic dysfunction in α-synucleinopathy
by: Sarkar, Souvarish, et al.
Published: (2022)

Investigating brain-derived α-synuclein fibrils and diagnostic biomarkers of synucleinopathies
by: Lee, S
Published: (2023)

Can olfactory bulb biopsy be justified for the diagnosis of Parkinson’s disease? Comments on “olfactory bulb α-synucleinopathy has high specificity and sensitivity for Lewy body disorders”
by: Parkkinen, L, et al.
Published: (2008)

Alpha-synuclein RT-QuIC in the CSF of patients with alpha-synucleinopathies
by: Parkkinen, L, et al.
Published: (2016)

The link between neuroinflammation and the neurovascular unit in synucleinopathies
by: Wang, Qing, et al.
Published: (2023)

Diagnostic value of cerebrospinal fluid alpha-synuclein seed quantification in synucleinopathies
by: Poggiolini, I, et al.
Published: (2021)

Large-scale analysis of association between LRP5 and LRP6 variants and osteoporosis.
by: van Meurs, J, et al.
Published: (2008)

LRP-dependent and -independent internalisation of TIMP-3
by: Scilabra, S, et al.
Published: (2011)

Influence of LRP5 polymorphisms on normal variation in BMD.
by: Koay, M, et al.
Published: (2004)

The extraction of LRP via functional data analysis techniques.
by: Zhao, Y, et al.
Published: (2012)

Inhibition of LRP1 shedding reverses cartilage matrix degradation in osteoarthritis
by: Yamamoto, K, et al.
Published: (2017)

Gut feelings about α-synuclein in gastrointestinal biopsies: biomarker in the making?
by: Ruffmann, C, et al.
Published: (2016)

Increased TIMP-3 expression alters the cellular secretome through dual inhibition of the metalloprotease ADAM10 and ligand-binding of the LRP-1 receptor
by: Scilabra, SD, et al.
Published: (2018)

Structural and functional studies of LRP6 ectodomain reveal a platform for Wnt signaling
by: Chen, S, et al.
Published: (2011)

Structural and functional studies of LRP6 ectodomain reveal a platform for Wnt signaling.
by: Chen, S, et al.
Published: (2011)

Structural and Functional Studies of LRP6 Ectodomain Reveal a Platform for Wnt Signaling
by: Chen, S, et al.
Published: (2011)

Lrp4 is a receptor for Agrin and forms a complex with MuSK.
by: Kim, N, et al.
Published: (2008)

LRP5 promotes adipose progenitor cell fitness and adipocyte insulin sensitivity
by: Loh, NY, et al.
Published: (2025)

Development of a monoclonal anti-ADAMTS-5 antibody that specifically blocks the interaction with LRP1
by: Santamaria, S, et al.
Published: (2017)

Applicability of current staging/categorization of α-synuclein pathology and their clinical relevance
by: Parkkinen, L, et al.
Published: (2008)

LRP-1-mediated endocytosis regulates extracellular activity of ADAMTS-5 in articular cartilage.
by: Yamamoto, K, et al.
Published: (2013)

Mutations in LRP5 and SOST are a rare cause of high bone mass in the general population
by: Duncan, E, et al.
Published: (2009)

Separating stimulus-driven and response-related LRP components with Residue Iteration Decomposition (RIDE).
by: Stürmer, B, et al.
Published: (2013)

Widespread and abundant α-synuclein pathology in a neurologically unimpaired subject
by: Parkkinen, L, et al.
Published: (2005)

Structure of the Wnt signaling enhancer LYPD6 and its interactions with the Wnt coreceptor LRP6
by: Zhao, Y, et al.
Published: (2018)

Prion-like α-synuclein pathology in the brain of infants with Krabbe disease
by: Hatton, C, et al.
Published: (2022)

Association of MAPT (tau) haplotype with the pathology of Parkinson's disease
by: Parkkinen, L, et al.
Published: (2013)

Relationship of Apolipoprotein E to Parkinson's disease-related alpha-synuclein pathology
by: Parkkinen, L, et al.
Published: (2013)

Low density lipoprotein receptor-related protein 1 (LRP1)-mediated endocytic clearance of a disintegrin and metalloproteinase with thrombospondin motifs-4 (ADAMTS-4): functional differences of non-catalytic domains of ADAMTS-4 and ADAMTS-5 in LRP1 binding.
by: Yamamoto, K, et al.
Published: (2014)

Cilia protein IFT88 regulates extracellular protease activity by optimizing LRP-1–mediated endocytosis
by: Coveney, C, et al.
Published: (2018)

WNT activates the AAK1 kinase to promote clathrin-mediated endocytosis of LRP6 and establish a negative feedback loop
by: Agajanian, M, et al.
Published: (2019)

Association between TGF-beta and LRP 5 and 6 genetic polymorphisms with fracture risk and bone mineral density in the EPOS study
by: Kaptoge, S, et al.
Published: (2006)

MMP-13 is constitutively produced in human chondrocytes and co-endocytosed with ADAMTS-5 and TIMP-3 by the endocytic receptor LRP1
by: Yamamoto, K, et al.
Published: (2016)

Structure of the dual mode Wnt regulator Kremen1 and insight into ternary complex formation with LRP6 and Dickkopf
by: Jones, E, et al.
Published: (2016)

Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture
by: Chia, R, et al.
Published: (2021)

Thymosin β4 mediates vascular protection via regulation of Low Density Lipoprotein Related Protein 1 (LRP1)
by: Munshaw, S, et al.
Published: (2019)

Region-specific deficits in dopamine, but not norepinephrine, signaling in a novel A30P α-synuclein BAC transgenic mouse.
by: Taylor, T, et al.
Published: (2014)

Thymosin beta 4 - a novel regulator of low density lipoprotein receptor related protein 1 (LRP1) in vascular disease
by: Munshaw, S, et al.
Published: (2019)